measles and rubella vaccine (live) (attenuated, freeze dried) (? 1000 ccid50 + ? 1000 ccid50)/0.5 ml( dose) parenteral ordinary
biological e. limited- - measles virus (cam-70 strain) + rubella virus (wistar ra 27/3 strain) - parenteral ordinary dry vials - (? 1000 ccid50 + ? 1000 ccid50)/0.5 ml( dose)
measles and rubella vaccine (10 doses)
m/s biological e, ltd - measles; rubella (live attenuated) - vaccine - 1000; 1000ccid50
measles and rubella vaccine (5 doses)
m/s biological e, ltd - measles; rubella (live attenuated) - vaccine - 1000; 1000ccid50
priorix
glaxosmithkline nz limited - measles vaccine, schwarz strain 1000 ccid50 (not less than); mumps virus, live attenuated, rit 4385 5012 ccid50 (not less than); ; rubella virus, wistar ra27/3 strain 1000 ccid50 (not less than) - powder for injection with diluent - 0.5 ml - active: measles vaccine, schwarz strain 1000 ccid50 (not less than) mumps virus, live attenuated, rit 4385 5012 ccid50 (not less than) rubella virus, wistar ra27/3 strain 1000 ccid50 (not less than) excipient: amino acids lactose mannitol sorbitol water for injection - priorix is indicated for the active immunisation against measles, mumps and rubella.
measles and rubella vaccine live, attenuated injection
serum institute of india ltd. 212/2, hadapsar, pune - 411028, india - clarified virus pool of measles, clarified virus - injection - each single human dose when reconstituted in a - viral vaccines: measlesvaccines
priorix tetra vaccine solution for injection
glaxosmithkline pharmaceutical kenya limited likoni road industrial area nairobi - measles mumps rubella and varicella vaccine (live - solution for injection - measles > 10^3.0 ccid503 mumps > 10^4.4 ccid503 - viral vaccines: measlesvaccines
priorix vaccine solution for injection
glaxosmithkline pharmaceutical kenya limited likoni road industrial area nairobi - measles mumps and rubella vaccine (live) - solution for injection - measles > 10^3.0 ccid503 mumps > 10^3.7 ccid503 - viral vaccines: measlesvaccines
priorix-tetra injection
glaxosmithkline ltd likoni rd industrial area p.o box 78392 - measles mumps rubella and varicella vaccine - injection - measles >103.0 ccid50 mumps virus > 103.7 - viral vaccines: measlesvaccines
lirugen measles virus vaccine
dow corning new zealand limited - measles vaccine - solution for injection - active: measles vaccine
mmr ii vaccine
merck sharp & dohme (new zealand) limited - measles vaccine 1000 tcid50 (at end of expiry); mumps vaccine 12500 tcid50 (at end of expiry); rubella vaccine 1000 tcid50 (at end of expiry) - suspension for injection - active: measles vaccine 1000 tcid50 (at end of expiry) mumps vaccine 12500 tcid50 (at end of expiry) rubella vaccine 1000 tcid50 (at end of expiry) excipient: dibasic potassium phosphate dibasic sodium phosphate monohydrate eagle minimum essential medium gelatin medium 199 monobasic potassium phosphate monobasic sodium phosphate monohydrate monosodium glutamate neomycin phenolsulfonphthalein sodium bicarbonate sorbitol sucrose water for injection - m-m-r ii is indicated for simultaneous vaccination against measles, mumps, and rubella in individuals 12 months of age or older.